Reminder + FIT Test Cost-Effective for Promoting CRC Screening
Reminder + FIT reduced costs per additional Medicaid enrollee screened compared with reminder only.
Colorectal Cancer
ACE Inhibitors Associated With Lower Colorectal Cancer Risk in Large Cohort Study
A team of investigators sought to determine if the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers were associated with the development of colorectal cancer.
No Benefit of Surgery Over Endoscopic Resection for T1 Colorectal Cancer
A team of investigators conducted a meta-analysis and systematic review to compare outcomes of endoscopic resection vs surgery for T1 colorectal cancer.
Keytruda Approved as First-Line Treatment of MSI-H or dMMR Colorectal Cancer
The FDA has approved Keytruda (pembrolizumab; Merck), a programmed death receptor-1 -blocking antibody, as monotherapy for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer.
Complications After Colonoscopy Up for Those Aged ≥75
Other factors associated with risk include anemia, cardiac arrhythmia, hypertension, smoking history, obesity
Antidiabetic Medication Adherence, Survival for Patients With Diabetes and Colorectal Cancer
Researchers assessed whether adherence to oral antidiabetic medication was a modifiable prognostic factor in patients with CRC and preexisting diabetes.
Racial/Ethnic Disparities in End-of-Life Care in a Medicaid Population
This study focused on a cohort of nonelderly Medicaid beneficiaries with stage IV breast or colorectal cancer who resided in New Jersey.
Family History-Based Early Screen Could ID More Young-Onset CRC
Almost all who met criteria for early screening could have initiated screening before age of diagnosis.
Impact of Nutritional Indices on the Survival Outcomes of Patients with Colorectal Cancer
[Cancer Management and Research] In this study, researchers investigated whether preoperative prognostic nutritional index, prealbumin, and the albumin to globulin ratio were predictive of survival outcomes for patients with colon and rectal cancers.
Neoadjuvant Immunotherapy Shows Promise in Early Colon Cancer
Immune checkpoint inhibition may even benefit some patients with MMR-proficient tumors.
-
Loading...
-
Loading...
Next post in Colorectal Cancer
